Table II.
Clinical-surgical characteristics of patients infected by COVID-19 and ALI
| Variables | Value (n = 30) | Percentage (%) |
|---|---|---|
| ALI time (hr) | 39 (12–72) | |
| Clinical manifestations of the ALI | ||
| No pulse | 30 | 100 |
| Pain | 28 | 93.3 |
| Cyanosis | 25 | 89.2 |
| Paresthesia | 25 | 89.2 |
| Pallor | 23 | 76.6 |
| Motor deficit | 7 | 23.3 |
| Rutherford staging | ||
| I | 0 | 0 |
| IIA | 23 | 76.6 |
| IIB | 5 | 16.6 |
| III | 2 | 6.6 |
| Surgical treatment of the ALI | ||
| Thrombectomy | 23 | 76.6 |
| Superior limb | 6 | 20 |
| Lower limb | 17 | 46.6 |
| Amputation | 9 | 30 |
| Primary | 5 | 16.6 |
| Superior limb | 1 | 3.3 |
| Lower limb | 4 | 13.3 |
| Secondary | 4 | 13.3 |
| Superior limb | 1 | 3.3 |
| Lower limb | 3 | 10 |
| No surgical treatment | 2 | 6.6 |
ALI, acute limb ischemia.